Internal Medicine, Hematology & Oncology · Hannibal, MO
NPI
1689721482
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
6
Medicare group memberships
Hospitals
5
Hospital affiliations
6500 Hospital Dr
Hannibal, MO, 63401
Phone (573) 629-3331
Groups this clinician bills Medicare through
Medicare paid, 2024
$39K
465 services
Medicare patients, 2024
159
Average age 73
Drug cost, 2024
$1.6M
704 prescriptions
Company payments, 2025
$955
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin T Palka was code 99214 (office e&m - established), 269 times for 85 patients. In total Kevin T Palka billed 465 services in 14 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 269 | 85 | $86.15 | $23K |
| 99213 Office E&M - Established | Office | 76 | 58 | $57.44 | $4,366 |
| 99215 Office E&M - Established | Office | 23 | 22 | $132.09 | $3,038 |
| 99205 Office E&M - New | Office | 19 | 19 | $144.91 | $2,753 |
| 90662 Vaccine Product | Office | 15 | 15 | $77.54 | $1,163 |
| G0008 Administration of influenza virus vaccine | Office | 15 | 15 | $9.80 | $147 |
| 99223 Hospital E&M - Initial | Facility | 14 | 11 | $128.29 | $1,796 |
By year: 2022 $43K for 470 services; 2023 $42K for 493 services; 2024 $39K for 465 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kevin T Palka prescribed most often to Medicare patients was Anastrozole, with 100 prescriptions and refills. In total Kevin T Palka wrote 704 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 100 | 143 | 20 | $1,077 |
| Tamoxifen Citrate Generic | 47 | 110 | 12 | $931 |
| Prednisone Generic | 37 | 37 | Under 11 | $95.76 |
| Potassium Chloride Generic | 37 | 49 | 13 | $619 |
| Letrozole Generic | 37 | 41 | Under 11 | $561 |
| Abiraterone Acetate Generic | 29 | 29 | Under 11 | $139K |
| Ondansetron Odt Ondansetron | 28 | 28 | 18 | $661 |
| Oxycodone Hcl Generic | 26 | 26 | Under 11 | $546 |
| Prochlorperazine Maleate Generic | 26 | 26 | 17 | $609 |
| Brukinsa Zanubrutinib | 26 | 26 | Under 11 | $390K |
| Gabapentin Generic | 25 | 27 | Under 11 | $134 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 19 | 19 | Under 11 | $826 |
| Morphine Sulfate Er Morphine Sulfate | 17 | 17 | Under 11 | $705 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 15 | 15 | Under 11 | $318 |
| Xtandi Enzalutamide | 14 | 14 | Under 11 | $203K |
Brand drugs: 113 claims; generic drugs: 591 claims; opioid claims: 106.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin T Palka $955 ($955 in general payments such as food, travel and fees) from 18 companies. The largest payer was Janssen Biotech, Inc. with $177.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 4 | $177 |
| Abbvie Inc. ABBV | 7 | $151 |
| Sobi, Inc SOBI.ST | 1 | $92.99 |
| Pfizer Inc. PFE | 5 | $89.63 |
| Tempus AI, Inc TEM | 1 | $72 |
| Merck Sharp & Dohme LLC MRK | 2 | $63.16 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $50.78 |
| Astellas Pharma US Inc 4503.T | 2 | $39.2 |
| Celgene Corporation BMY | 2 | $33.21 |
| Incyte Corporation INCY | 2 | $33.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.